| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Dihydromyricetin | Breast Cancer | 10 | PM | 36692465 | 📋 | Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo |
| Dihydromyricetin | Breast Cancer | 8 | PM | 35365444 | 📋 | [Dihydromyricetin reverses Herceptin resistance by up-regulating miR-98-5p and inhibiting IGF1R/HER2 dimer formation in SKBR3 cells] |
| Dihydromyricetin | Breast Cancer | 9 | PM | 34470980 | 📋 | Ampelopsin Inhibits Breast Cancer Cell Growth through Mitochondrial Apoptosis Pathway |
| Dihydromyricetin | Breast Cancer | 7 | PM | 34451892 | 📋 | Ampelopsin Suppresses Stem Cell Properties Accompanied by Attenuation of Oxidative Phosphorylation in Chemo- and Radio-Resistant MDA-MB-231 Breast Cancer Cells |
| Dihydromyricetin | Breast Cancer | 6 | PM | 31323836 | 📋 | Ampelopsin E Reduces the Invasiveness of the Triple Negative Breast Cancer Cell Line, MDA-MB-231 |
| Dihydromyricetin | Breast Cancer | 5 | PM | 27609190 | 📋 | Induction of apoptosis and G2/M arrest by ampelopsin E from Dryobalanops towards triple negative breast cancer cells, MDA-MB-231 |
| Dihydromyricetin | Breast Cancer | 4 | PM | 25088800 | 📋 | Ampelopsin-induced autophagy protects breast cancer cells from apoptosis through Akt-mTOR pathway via endoplasmic reticulum stress |
| Dihydromyricetin | Breast Cancer | 3 | PM | 24861637 | 📋 | Ampelopsin suppresses breast carcinogenesis by inhibiting the mTOR signalling pathway |
| Dihydromyricetin | Breast Cancer | 2 | PM | 24551210 | 📋 | Ampelopsin induces cell growth inhibition and apoptosis in breast cancer cells through ROS generation and endoplasmic reticulum stress pathway |
| Dihydromyricetin | Breast Cancer | 1 | PM | 22251058 | 📋 | Resveratrol dimers are novel sphingosine kinase 1 inhibitors and affect sphingosine kinase 1 expression and cancer cell growth and survival |
| Dihydromyricetin | Cervical Cancer | 1 | PM | 36499426 | 📋 | Dihydromyricetin Inhibited Migration and Invasion by Reducing S100A4 Expression through ERK1/2/β-Catenin Pathway in Human Cervical Cancer Cell Lines |
| Dihydromyricetin | Choriocarcinoma | 2 | PM | 32565961 | 📋 | Inhibitory effect of dihydromyricetin on the proliferation of JAR cells and its mechanism of action |
| Dihydromyricetin | Choriocarcinoma | 1 | PM | 30214558 | 📋 | Dihydromyricetin induces apoptosis in a human choriocarcinoma cell line |
| Dihydromyricetin | Infertility Female | 1 | PM | 36403957 | 📋 | Dihydromyricetin supplementation during in vitro culture improves porcine oocyte developmental competence by regulating oxidative stress |
| Dihydromyricetin | Ovarian Cancer | 3 | PM | 31770410 | 📋 | Golgi reassembly and stacking protein 65 downregulation is required for the anti-cancer effect of dihydromyricetin on human ovarian cancer cells |
| Dihydromyricetin | Ovarian Cancer | 2 | PM | 28436480 | 📋 | Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin |
| Dihydromyricetin | Ovarian Cancer | 1 | PM | 25502786 | 📋 | Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition |
